← Back to Search

Drug Interaction Study in Healthy Subjects

Phase 1
Recruiting
Research Sponsored by Celgene
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial aims to see how taking itraconazole or rifampin along with golcadomide affects the levels of golcadomide in the body.

Who is the study for?
This trial is for healthy individuals who can safely take the medications involved. Specific eligibility details are not provided, but typically participants should have no significant health issues that could interfere with the study.
What is being tested?
The study is testing how golcadomide levels change when taken with either itraconazole or rifampin. These drugs affect liver enzymes and could alter how golcadomide is processed in the body.
What are the potential side effects?
Possible side effects may include reactions to itraconazole such as nausea, rash, or liver problems; rifampin might cause upset stomach or even flu-like symptoms; and golcadomide's side effects aren't specified here.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Group I: Part 2Experimental Treatment2 Interventions
Group II: Part 1Experimental Treatment2 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Itraconazole
2017
Completed Phase 2
~830
Rifampin
2011
Completed Phase 3
~2140

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

CelgeneLead Sponsor
645 Previous Clinical Trials
130,513 Total Patients Enrolled
Bristol-Myers SquibbStudy DirectorBristol-Myers Squibb
1,559 Previous Clinical Trials
3,383,680 Total Patients Enrolled
~24 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top